Veterinary Medicines

Drontal Oral Suspension for Puppies 15/5 mg/ml

Authorised
  • Febantel
  • Pyrantel embonate
Download as PDF

Product identification

Medicine name:
Drontal Oral Suspension for Puppies 15/5 mg/ml
Welpan vet. 15 mg/ml + 5 mg/ml mikstur, suspensjon
Active substance:
  • Febantel
  • Pyrantel embonate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Febantel
    15.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Pyrantel embonate
    14.40
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral suspension
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AF02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Norway
Package description:
  • Material of the primary container:White high density polyethylene bottle.White polypropylene screw closure.Colourless low density polyethylene adapter insert.Container volume:100ml.Devices supplied (if relevant):5ml transparent polypropylene syringe with rubber plunger.
  • Material of the primary container:White high density polyethylene bottle.White polypropylene screw closure.Colourless low density polyethylene adapter insert.Container volume:50ml.Devices supplied (if relevant):5ml transparent polypropylene syringe with rubber plunger.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetoquinol S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinaer Produkte GmbH
  • Vetoquinol Biowet Sp. z o.o.
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 07-5484
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0473/001
Concerned member states:
  • Austria
  • Estonia
  • Finland
  • France
  • Germany
  • Iceland
  • Latvia
  • Lithuania
  • Norway
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 26/01/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Norwegian (PDF)
Published on: 10/12/2024
Download

Combined File of all Documents

English (PDF)
Published on: 16/11/2025
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."